Key Metrics
CiteScore 

0.1
Recommended pre-submission checks
Powered by 

Archivos de prevención de riesgos laborales Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Societat Catalana de Seguretat i Medicina del Treball (SCSMT) |
| Language | Spanish,Catalan |
| Publication Time | 20 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Spanish,Catalan |
| Website URL | Visit website |
| Publication Details | |
| Publication Time | 20 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Dulcinea |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Archivos de prevención de riesgos laborales ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Archivos de prevención de riesgos laborales
MORPHEUS-Lung: biomarkers and clinical response to atezolizumab+bevacizumab+stereotactic body radiotherapy in patients with metastatic non-small cell lung cancer.
- 16 Apr 2027
- Lung cancer (Amsterdam, Netherlands)
Prognostic value of serum CYFRA21-1 in locally advanced non-small cell lung cancer undergoing durvalumab consolidation therapy after chemoradiotherapy
- 1 Jul 2026
- Lung Cancer
Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
New conversations in an old argument: Lessons learnt from the PIONEER randomised feasibility study in resectable stage III-N2 NSCLC.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
Association of tumor CD73 expression with clinical outcomes in small cell lung cancer treated with first-line chemo-immunotherapy.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
MORPHEUS-Lung: biomarkers and clinical response to atezolizumab+bevacizumab+stereotactic body radiotherapy in patients with metastatic non-small cell lung cancer.
- 16 Apr 2027
- Lung cancer (Amsterdam, Netherlands)
Prognostic value of serum CYFRA21-1 in locally advanced non-small cell lung cancer undergoing durvalumab consolidation therapy after chemoradiotherapy
- 1 Jul 2026
- Lung Cancer
Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
New conversations in an old argument: Lessons learnt from the PIONEER randomised feasibility study in resectable stage III-N2 NSCLC.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
Association of tumor CD73 expression with clinical outcomes in small cell lung cancer treated with first-line chemo-immunotherapy.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung.
- 1 Jun 2026
- Lung cancer (Amsterdam, Netherlands)
FAQs on Archivos de prevención de riesgos laborales
How many articles did Archivos de prevención de riesgos laborales publish last year? 
What is the eISSN & pISSN for Archivos de prevención de riesgos laborales? 
What is Citescore for Archivos de prevención de riesgos laborales? 
Who is the publisher of Archivos de prevención de riesgos laborales? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary